Trade Spotlight: How should you trade PB Fintech, Century Plyboards, Grasim, Dr Reddys Labs, Zydus Lifesciences, and others on December 12?

Top Trading Ideas for December 12

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Equity benchmarks bounced back smartly, rising more than half a percent after the correction seen in previous three sessions. The market breadth also turned positive, as about 1,746 shares gained against 1,081 declining shares on the NSE. The market is expected to gain further strength if the benchmarks reclaim the 20-day SMA. Below are some short-term trading ideas to consider:

PB Fintech is displaying a strong bullish structure on the daily chart, marked by a decisive breakout above a year-long descending trendline, signalling a major shift in control toward buyers. This breakout comes after weeks of higher-low formations, reflecting steady accumulation and improving trend maturity.

Price action remains firmly above the 20-DEMA, indicating strong short-term momentum, while rising volumes confirm institutional participation behind the move. The RSI above 60 reinforces strengthening momentum without signs of exhaustion. With this structural breakout and trend alignment, the stock opens room toward Rs 2,120, while Rs 1,860 acts as the key support protecting the bullish bias.

Strategy: Buy

Target: Rs 2,120

Stop-Loss: Rs 1,860

Century Plyboards is displaying a strong bullish structure supported by a confluence of breakout signals on the daily chart. The stock has cleared a major horizontal resistance zone near Rs 820–825, coinciding with a cup-and-handle breakout, strengthening the validity of the up-move. Price action has been consistently forming higher highs and higher lows, reflecting sustained bullish control.

The stock is trading firmly above the 20-DEMA, reinforcing trend strength, while the RSI is hovering above 60, highlighting improving momentum. With this multi-level breakout alignment, the structure opens upside potential toward Rs 915, while Rs 800 serves as the key support safeguarding the bullish setup.

Strategy: Buy

Target: Rs 915

Stop-Loss: Rs 800

Grasim Industries is approaching a crucial bullish inflection zone as the stock edges toward its neckline resistance near the Rs 2,820–2,840 band after forming a well-defined rounded-base structure over the last several weeks. This basing pattern reflects steady accumulation after a corrective phase, with price stabilising above the 200-DEMA, indicating strong underlying trend support.

The stock recently rebounded sharply from its short-term floor, showing a shift in momentum as it attempts to retest the neckline resistance. Notably, the stock is also positioned just below an unfilled gap zone, increasing the probability of a gap-fill move on any sustained breakout above the neckline.

Momentum has strengthened, with the RSI climbing above 57 and turning upward, signalling improving buying pressure. The structure opens room for an upside toward Rs 2,950, while Rs 2,715 serves as key support protecting the developing bullish base.

Strategy: Buy

Target: Rs 2,950

Stop-Loss: Rs 2,715

Dr Reddy’s Laboratories is showing clear signs of strength after forming a strong bullish closing candle. On the downside, the stock has been taking strong support near Rs 1,250, which aligns with the 200-day EMA and indicates sustained demand in that zone.

Recently, price action has developed a descending triangle pattern, and the stock is now approaching a crucial trendline resistance near Rs 1,280. A decisive break and sustained move above this level may signal the beginning of the next upside leg.

The stock is comfortably trading above the key 20, 50, 100, and 200 EMAs, confirming a positive structure. The RSI is placed around 60.31, showing improving momentum with a higher-high formation. Short-term traders may consider buying at current levels.

Strategy: Buy

Target: Rs 1,360

Stop-Loss: Rs 1,225

Bajaj Auto has recently given a sideways range breakout followed by a successful retest. This price action indicates renewed strength and steady accumulation. On the downside, the stock continues to hold firm support at the breakout zone, which is further strengthened by the 200-day EMA near Rs 8,750, acting as a strong demand area.

On the upside, the stock is facing immediate resistance around Rs 9,100. A decisive break and sustained move above this level would confirm bullishness and potentially trigger the next leg of upward momentum. The stock maintains a positive structure as it trades comfortably above the 20, 50, 100, and 200 EMAs, reflecting strong underlying trend strength.

RSI is currently placed at 53.86, supporting continuation of the ongoing uptrend with improving momentum.

Strategy: Buy

Target: Rs 9,700

Stop-Loss: Rs 8,700

Lupin has been taking steady support and is moving in a clear higher-high, higher-low structure, indicating sustained bullish momentum. This price behaviour reflects renewed buying interest as the stock continues to build strength.

Recently, Lupin gave a wider-range trendline-resistance breakout, followed by a successful retest, which further confirms the continuation of its upward trajectory. The price action remains positive as the stock trades comfortably above the key 20, 50, 100, and 200 EMAs, reinforcing its strong technical structure and supporting the ongoing uptrend.

RSI is currently placed at 59.53, signalling improving momentum and a continuation of bullish sentiment.

Strategy: Buy

Target: Rs 2,280

Stop-Loss: Rs 1,980

AIA Engineering built a solid base in the Rs 3,050–3,400 zone with a clear double bottom and strong positive RSI divergence. November 2025 delivered a high-volume breakout. The structure has started forming bullish with higher highs and higher lows. A move above Rs 3,835 should trigger the next strong leg higher. Weekly RSI and MACD are trading in bullish territory. Recent price action is hinting at a healthy throwback to retest the breakout zone.

Strategy: Buy

Target: Rs 3,980, Rs 4,200

Stop-Loss: Rs 3,385

Zydus Lifesciences remains under pressure, trading below all key EMAs inside a well-defined downward-sloping channel. It is consistently forming lower highs and lower lows. The recent breakdown below the trendline support came on expanding volume, confirming bearish continuation.

Daily and weekly RSI are both below 50 and declining. Every minor bounce meets stiff selling near the 20-day EMA, reinforcing overhead supply.

Strategy: Sell

Target: Rs 900, Rs 885

Stop-Loss: Rs 954